melanoma

FDA approves breakthrough cancer gene testFDA approved a new cancer biomarker test that can detect genetic mutations in 324 genes and 2 genomic signatures in tumors.
Melanoma research roundupIn this slideshow, we highlight recently published research findings on newly identified genetic mutations associated with conjunctival melanoma, expanding the definition of melanoma to include population diversities, and dermatomyositis that fails treatment.
Revised melanoma staging criteriaStaging system is derived from a new dataset of patients from 10 cancer centers around the world. Dermatologists should consider AJCC tumor characteristics as well as other factors in risk assessment, counseling, and follow-up plans for patients. Update takes effect in January 2018.
SLNB for melanomaBiopsy can differentiate risk level for patients, but selectively indicated
Melanoma tumor suppressorA known oncogene previously associated with carcinomas of the breast, liver, ovaries, and colon appears to suppress the growth of melanoma cells, a team of researchers reported recently in Cell Reports.
Kyocera develops image recognition technology for skin disease identificationKyocera Communication Systems, a subsidiary of Kyocera, is teaming with the University of Tsukuba to created artificial intelligence (AI)-based technology that could identify skin cancers and other skin diseases.
Switching from an AIMP to a melanoma diagnosisSignificant residual pigment may indicate elevated melanoma risk in atypical intraepidermal melanocytic proliferation (AIMP) lesions.
Changing moles in teens
Changing moles in teensMole count in adolescents predictor of melanoma. Sun exposure habits develop in teen years. Prevent melanoma through sun protection. Reduce the number of unnecessary biopsies.
Cutaneous side effects of melanoma drugsDermatologists need “hands on” experience, researchers say at EADV 2017.
Update: Immunotherapeutic options in advanced melanomaAt EADV, Dr. Simone Ribero reviews the latest data on new treatments for advanced melanoma.